査読付原著論文
総説・書籍（英語）
投稿中論文

総説・書籍（英語）

Invited Review Articles or Book Chapters in English

2023年

  1. Kobayashi H, Choyke PL, Ogawa M.
    The chemical basis of cytotoxicity of near infrared photoimmunotherapy (NIR-PIT) and its
    implications for treatment monitoring.
    Current Opinion in Chemical Biology 2023 (in press)

2022年

  1. Furumoto H, Kato T, Wakiyama H, Furusawa A, Choyke PL, Kobayashi H.
    Endoscopic applications of near-infrared photoimmunotherapy (NIR-PIT) in cancers of the
    digestive and respiratory tracts.
    Biomedicines 2022 ;10(4):846. doi: 10.3390/biomedicines10040846
  2. Fukushima H, Turkbey B, Pinto P, Furusawa A, Choyke PL, Kobayashi H.
    Near-infrared photoimmunotherapy (NIR-PIT) in urologic cancers.
    Cancers 2022 ;14(12):2996. doi: 10.3390/cancers14122996.
  3. Furusawa A, Choyke PL, Kobayashi H.
    NIR-PIT; Will it become a standard cancer treatment?
    Frontiers in Oncology 2022 ;12:1008162. doi: 10.3389/fonc.2022.1008162.
  4. Okada R, Furusawa A, Choyke PL, Kobayashi H.
    Quantitative Assessment of the Efficacy of Near-infrared Photoimmunotherapy with
    Bioluminescence Imaging.
    Methods in Molecular Biology 2022; 2525: 3-13. doi: 10.1007/978-1-0716-2473-9_1.

2021年

  1. Wakiyama H, Kato T, Furusawa A, Choyke PL, Kobayashi H.
    Near infrared photoimmunotherapy of cancer; possible clinical applications.
    Nanophotonics 2021; 10(12): 3135–3151.
  2. Kobayashi H.
    Expanding the application of cancer near-infrared photoimmunotherapy (Commentary)
    EBioMedicine 2021; 68: 103416. doi.org/10.1016/j.ebiom.2021.103416
  3. Kato T, Wakiyama H, Furusawa A, Chyke PL, Kobayashi H.
    Near infrared photoimmunotherapy; a review of targets for cancer therapy.
    Cancers 2021;13(11):2535.
  4. Maruoka Y, Wakiyama H, Choyke PL, Kobayashi H.
    Near infrared photoimmunotherapy for cancers: a translational perspective.
    EBioMedicine 2021 ;70:103501.
  5. Kobayashi H, Choyke PL.
    Future applications and prospects of NIR-PIT; benefits and differences when compared to
    PDT and PTT
    Immunotherapy 2021;13(16):1305-1307.